News
company
year
domain
Flagship Pioneering Announces Appointment of Pablo J. Cagnoni, M.D., as Executive Partner
11.02.2022
Seres Therapeutics Announces FDA Acceptance of Biologics License Application for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection for Priority Review
Seres Therapeutics 10.26.2022
Flagship Pioneering Launches Apriori Bio to Provide Variant-Proof Protection from the Greatest Viral Threats
Apriori Bio 07.11.2022